Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas

British Journal of Cancer

Volumn 74, Issue 12, 1996, Pages 1862-1868

  Olivero, M ^a   Rizzo, M ^a   Madeddu, R ^b   Casadio, C ^a   Pennacchietti, S ^a   Nicotra, M R ^c   Prat, M ^a   Maggi, G ^a   Arena, N ^b   Natali, P G ^c   Comoglio, P M ^a   Di Renzo, M F ^b,d  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d Università Degli Studi di Sabari   (Italy)

Author keywords

Hepatocyte growth factor scatter factor; Human cancer; Met receptor; Non small cell lung cancer

Indexed keywords

GROWTH FACTOR RECEPTOR; PROTEIN PRECURSOR; SCATTER FACTOR;

ADULT; AGED; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

EID: 8044219670     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.646     Document Type: Article

References (55)

1. ANKRAPP DP AND BEVAN DR. (1993). Insulin-like growth factor-1 and human lung fibroblast-derived insulin-like growth factor 1 stimulate the proliferation of human lung carcinoma cells in vitro. Cancer Res., 53, 3399-3404.
2. BELLUSCI S, MOENS G, GAUDINO G, COMOGLIO PM, NAKAMURA T, THIERY JP AND JOUANNEAU J. (1994). Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene, 9, 1091-1099.
3. BUSSOLINO F, DI RENZO MF, ZICHE M, BOCCHIETTO E, OLIVERO M, NALDINI L, GAUDINO G, TAMAGNONE L, COFFER A AND COMOGLIO PM. (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol., 119, 629-641.
4. CARBONE DP, MITSUDOMI T, CHIBA I, PIANTADOSI S, RUSCH V, NOWAK JA, MCINTIRE D, SLAMON D, GAZDAR A AND MINNA J. (1994). P53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small-cell lung cancer. Chest (suppl.), 106, 377-381.
5. COMOGLIO PM. (1993). Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. In Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the c-Met receptor, Goldberg ID and Rosen EM. (eds) pp. 131-165. Birkauser: Basle.
6. COOPER CS, PARK M, BLAIR DG, TAINSKY M, HUEBNER K, CROCE CM AND VANDE WOUDE GF. (1984). Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature, 311, 29-33.
7. DEFRANCES MC, WOLF HK, MICHALOPOULOS GK AND ZARNEGAR R. (1992). The presence of hepatocyte growth factor in the developing rat. Development, 116, 387-395.
8. DI RENZO MF, NARSIMHAN RP, OLIVERO M, BRETTI S, GIORDANO S, MEDICO E, GAGLIA P, ZARA P AND COMOGLIO PM. (1991). Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene, 6, 1997-2003.
9. DI RENZO MF, OLIVERO M, FERRO S, PRAT M, BONGARZONE I, PILOTTI S, PIEROTTI M AND COMOGLIO PM. (1992). Overexpression of the c-Met/HGF receptor gene in human thyroid carcinomas. Oncogene, 7, 2549-2553.
10. DI RENZO MF, OLIVERO M, KATSAROS D, CREPALDI T, GAGLIA P, ZOLA P, SISMONDI P AND COMOGLIO PM. (1994). Overexpression of the Met/HGF receptor in ovarian cancer. Int. J. Cancer, 58, 658-662.
11. DI RENZO MF, POULSOM R, OLIVERO M, COMOGLIO PM AND LEMOINE NR. (1995a). Expression of the Met/HGF receptor in human pancreatic cancer. Cancer Res., 5, 1129-1138.
12. DI RENZO MF, OLIVERO M, GIACOMINI A, PORTE H, CHASTRE E, MIROSSAY L, NORDLINGER B, BRETTI S, BOTTARDI S, GIORDANO S, PLEBANI M, GESPACH C AND COMOGLIO PM. (1995b). Overexpression and amplification of the Met HGH receptor gene during the progression of colorectal cancer. Clin. Cancer Res., 1, 147-154.
13. GIORDANO S, PONZETTO C, DI RENZO MF, COOPER CS AND COMOGLIO PM. (1989). Tyrosine kinase receptor indistinguishable from the c-met protein. Nature, 339, 155-156.
14. GIORDANO S, ZHEN Z, MEDICO E, GAUDINO G, GALIMI F AND COMOGLIO PM. (1993). Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene. Proc. Natl Acad. Sci. USA, 90, 649-653.
15. GOLDBERG ID AND ROSEN EM. (1993). Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the c-Met receptor. Birkhauser: Basle.
16. GRANT DS, KLEINMAN HK, GOLDBERG ID, BHARGAVA MM, NICKOLOFF BJ, KINSELLA JL, POLVERINI P AND ROSEN EM. (1993). Scatter factor induces blood vessel formation in vivo. Proc. Natl Acad. Sci. USA, 9, 1937-1941.
17. IYER A, KMIECIK TE, PARK M, DAAR I, BLAIR D, DUNN J, SUTRAVE P, IHLE JN, BODESCOT M AND VANDE WOUDE G. (1990). Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Diff., 1, 87-95.
18. LIU C AND TSAO M-S. (1993). In vitro and in vivo expressions of transforming growth factor-α and tyrosine kinase receptors in human non-small-cell lung carcinomas. Am. J. Pathol., 142, 1155-1162.
19. LIU G, SHUMAN MA AND COHEN RL. (1995). Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int. J. Cancer, 60, 501-506.
20. LIU Y, BEEDLE AB, LIN L, BELL AW AND ZARNEGAR R. (1994). Identification of a cell-type-specific transcriptional repressor in the promoter region of the mouse hepatocyte growth factor gene. Mol. Cell. Biol., 14, 7046-7058.
21. MARS WM, ZARNEGAR R AND MICHALOPOLOUS G. (1993). Activation of an hepatocyte growth factor by the plasminogen activators uPA and tPA. Am. J. Pathol., 143, 949-958.
22. MASON RJ, LESLIE CC, MCCORMICK SHANNON K, DETERDING RR, NAKAMURA T, RUBIN JS AND SHANNON JM. (1994). Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am. J. Resp. Cell Mol. Biol., 11, 561-567.
23. MASUMOTO A AND YAMAMOTO N. (1991). Sequestration of a hepatocyte growth factor in extracellular matrix in normal adult rat liver. Biochem. Biophys. Res. Comm., 174, 90-95.
24. MATSUMOTO K, TAJIMA H, HAMANOUE M, KOHNO S, KINOSHITA T AND NAKAMURA T. (1992a). Identification and characterization of 'injurin,' an inducer of expression of the gene for hepatocyte growth factor. Proc. Natl Acad. Sci. USA, 89, 3800-3804.
25. MATSUMOTO K, TAJIMA H, OKAZAKI H AND NAKAMURA T. (1992b). Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor -β1 and glucocorticoids. J. Biol. Chem., 267, 24917-24920.
26. MIYAZAWA K, SHIMOMURA T, KITAMURA A, KONDO J, MORIMOTO Y AND KITAMURA N. (1993). Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J. Biol. Chem., 268, 10024-10028.
27. MIYAZAWA K, SHIMOMURA T, NAKA D AND KITAMURA N. (1994). Proteolytic activation of hepatocyte growth factor in response to tissue injury. J. Biol. Chem., 269, 8966-8970.
28. MIZUNO K, TAKEHARA T AND NAKAMURA T. (1992). Proteolitic activation of a single-chain precursor of hepatocyte growth factor by extracellular serine-protease. Biochem. Biophys. Res. Comm., 189, 1631-1633.
29. MOGHUL A, LIN L, BEEDLE A, KANBOUR-SHAKIR, DE FRANCES MC, LIU Y AND ZARNEGAR R. (1994). Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene, 9, 2045-2052
30. MONTESANO R, MATSUMOTO K, NAKAMURA T AND ORCI L. (1991). Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell,67, 901-908.
31. MOUNTAIN CF. (1986). A new international staging system for lung cancer. Chest, 89, 225-323.
32. NAGAYAMA M, SATO A, HAYAKAWA H, URANO T, TAKADA Y AND TAKADA A. (1994). Plasminogen activators and their inhibitors in non-small cell lung cancer: low content of type 2 plasminogen activator inhibitor associated with tumor dissemination. Cancer, 73, 1398-1405.
33. NAKA D, ISHII T, YOSHIYAMA Y, MIYAZAWA K, HARA H, HISHIDA T AND KITAMURA N. (1992). Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J. Biol. Chem., 267, 20114-20119.
34. NALDINI L, WEIDNER M, VIGNA E, GAUDINO G, BARDELLI A, PONZETTO C, NARSIMHAN R, HARTMANN G, ZARNEGAR R, MICHALOPOULOS G, BIRCHMEIER W AND COMOGLIO PM. (1991). Scatter factor and hepatocyte growth factor are indistinguishable ligands for the Met receptor. EMBO J., 10, 2867-2878.
35. NALDINI L, TAMAGNONE L, VIGNA E, SACHS M, HARTMANN G, BIRCHMEIER W, DAIKUHARA Y, TSUBOUCHI H, BLASI F AND COMOGLIO PM. (1992). Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/ scatter factor. EMBO J., 11, 4825-4833
36. NALDINI L, VIGNA E, BARDELLI A, FOLLENZI A, GALIMI F AND COMOGLIO PM. (1995). Biological activation of Pro-HGF (hepatocyte growth factor) by urokinase is controlled in vivo by a stoichiometric reaction. J. Biol. Chem., 270, 603-611.
37. NATALI PG, NICOTRA MR, BIGOTTI A, VENTURO I, SLAMON DJ, FENDLY BM AND ULLRICH A. (1990). Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues. Int. J. Cancer, 45, 457-461.
38. PARK M, DEAN M, COOPER CS, SCMIDT M, O'BRIEN SJ, BLAIR DG AND VANDE WOUDE GF. (1986). Mechanism of met oncogene activation. Cell, 45, 895-904.
39. PLASCHKE-SCHLUTTER A, BEHERENS J, GHERARDI E AND BIRCHMEIER W. (1995). Characterization of the scatter factor/ hepatocyte growth factor gene promoter. J. Biol. Chem., 270, 830-836.
40. PRAT M, NARSIMHAN RP, CREPALDI T, NICOTRA MR, NATALI PG AND COMOGLIO PM. (1991). The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer. 49, 323-328.
41. RONG S, SEGAL S, ANVER M, RESAU JH AND VANDE WOUDE G. (1994). Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor autocrine stimulation. Proc. Natl Acad. Sci. USA, 91, 4731-4735.
42. ROSELL R, LI S, SKACEL Z, MATE JL, MAESTRE J, CANELA M, TOLOSA E, ARMENGOL P, BARNADAS A AND ARIZA A. (1993). Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogene, 8, 2407-2412.
43. RUBIN JS, CHAN AM-L, BOTTARO D, BURGESS WH, TAYLOR WG, CECH AC, HIRSCHFIEL DW, WONG J, MIKI T, FINCH PW AND AARONSON S. (1991). A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc. Natl Acad. Sci. USA, 88, 415-419.
44. SHIMOMURA T, MIYAZAWA K, KOMIYAMA Y, HIKAORA H, NAKA D, MORIMOTO Y AND KITAMURA N. (1995). Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur. J. Biochem., 229, 257-261.
45. SONNEMBERG E, MEYER D, WEIDNER MK AND BIRCHMEIER C. (1993). Scatter factor, hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell. Biol., 123, 223-235.
46. STOKER M, GHERARDI E, PERRYMAN M AND GRAY J. (1987). Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature (London), 327, 239-242.
47. TAMURA M, ARAKAKI N, TSUBOUCHI H, TAKADA H AND DAIKUHARA Y. (1993). Enhancement of human hepatocyte growth factor production by interleukin-1β and -1β and tumor necrosis factor-α by fibroblasts in culture. J. Biol. Chem., 268, 8140-8145.
48. TANG WX, MIYAZAWA K AND KITAMURA N. (1995). Hepatocyte growth factor remains as an inactive single chain after partial hepatectomy and unilateral nephrectomy. FEBS Lett., 362, 220-224.
49. TASHIRO K, HAGIYA M, NISHIZAWA T, SEKI T, SHIMONISHI M, SHIMIZU S AND NAKAMURA T. (1990). Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc. Natl Acad. Sci. USA, 87, 3200-3204.
50. TSAO M-S, ZHU H, GIAID A, VIALLET J, NAKAMURA T AND PARK M. (1993). Hepatocyte growth factor scatter factor is an autocrine factor for human bronchial epithelial and lung carcinoma cells. Cell Growth Diff., 4, 571-579.
51. WEIDNER KM, BEHRENS J, VANDEKERCKOVE J AND BIRCHMEIER W. (1990). Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol., 111, 2097-2108.
52. WEIDNER KM, SACHS M AND BIRCHMEIER W. (1993). The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor hepatocyte growth factor in epithelial cells. J. Cell Biol., 121, 145-154.
53. YANAGITA K, NAGAIKE M, ISHIBASHI H, NIHO Y, MATSUMOTO K AND NAKAMURA T. (1992). Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem. Biophys. Res. Commun., 182, 802-809.
54. YANAGITA K, MATSUMOTO K, SEKIGUCHI K, ISHIBASHI H, NIHO Y AND NAKAMURA T. (1993). Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J. Biol. Chem., 268, 21212-21217.
55. YU D, WANG S-S, DULSKI KM, TSAI C-M, NICOLSON GL AND HUNG M-C. (1994). c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res., 54, 3260-3266.